Search

Craig S Atwood

from Fitchburg, WI
Age ~60
Get Report
Also known as:
Craig Dr Atwood, Craig Living Atwood, Craig Atwood Living, Craig S Baird, Cat Wood
Related to:
Ronald A Iacoboni, 39
Connected to:
Ana E Atwood, 58Brook M Atwood, 44Bruce S Atwood, 70Cameron R Atwood, 48Charlene K Atwood, 67Christopher P Atwood, 60Derrick R Atwood, 53Dustin M Atwood, 42Gay W Atwood, 66Irving H Atwood, 108

Craig Atwood Phones & Addresses

  • Fitchburg, WI
  • 4825 Woodburn Dr, Madison, WI 53711 (608) 204-9566
  • 1125 Red Tail Dr, Verona, WI 53593 (608) 848-1235 (608) 848-4210
  • 7520 Sanctuary Cir, Brecksville, OH 44141 (440) 526-4442
  • Cleveland, OH
  • Sagamore Hills, OH
  • Dane, WI
  • Bethesda, MD
  • Elizabethtown, KY
  • Somerville, MA

Work

Position: Construction and Extraction Occupations

Education

Degree: High school graduate or higher

Resumes

Resumes

Craig Atwood Photo 1

Chief Executive Officer

View page
Location:
3033 Stamford Pl, Fitchburg, WI
Industry:
Research
Work:
American Society For Biochemistry and Molecular Biology (Asbmb) Jul 2011 - Aug 2016
Editorial Board
Jangobio Jul 2011 - Aug 2016
Chief Executive Officer
Wisconsin Alzheimers Institute Aug 2003 - 2013
Research Director
Wisconsin Comprehensive Research Program Aug 2003 - 2013
Research Director
Live Longer Foundation Aug 2003 - 2013
Board Member
Education:
Harvard Medical School 1995 - 1997
Skills:
Neuroscience
Cell Biology
Animal Models
Science
Protein Chemistry
Molecular Biology
Research
Life Sciences
Cell Culture
Clinical Research
Alzheimer's Disease
Genetics
Cancer
Physiology
Medical Research
Biochemistry
Public Speaking
Laboratory
Cell
Lifesciences
Drug Discovery
In Vitro
Developmental Biology
Immunohistochemistry
Oncology
Biology
Genomics
Western Blotting
Pharmacology
Microscopy
Scientific Writing
Gerontology
Endocrinology
Embryonic Stem Cells
Neurobiology
Epidemiology
Neuroendocrinology
Hormone Replacement Therapy
Aging
Education
Longevity
Bio Identical Hormone Replacement
Stem Cell Technology
Interests:
Oxidative Stress
Tau/Cytoskeleton
Neuropathology
Cell Cycle
See 17+See Less
Animal Models
Alzheimer's Disease
Hormone Biology
Tauopathies
Neuromuscular Disorders
Apoptosis
Regeneration
Biological Areas
Research Focus
Developmental Biology
Gerontology
Stem Cell Biology
Neurobiology
Protein Structure/Chemistry
Cancer
Prion Diseases
Etc
See Less
(Neuro)Endocrinology
See 11
Molecular and Cell Biology
Parkinson Disease
Stem Cells
A Betapp/ A Beta
Craig Atwood Photo 2

Craig Atwood

View page
Craig Atwood Photo 3

Craig Atwood

View page

Publications

Isbn (Books And Publications)

Community of the Cross: Moravian Piety in Colonial Bethlehem

View page
Author

Craig D. Atwood

ISBN #

0271023678

Handbook of Denominations in the United States

View page
Author

Craig D. Atwood

ISBN #

0687057841

Handbook of Denominations in the United States

View page
Author

Craig D. Atwood

ISBN #

0687069831

Always Reforming: A History of Christianity Since 1300

View page
Author

Craig D. Atwood

ISBN #

0865546797

Us Patents

Methods For Identifying An Agent That Inhibits Oxygen-Dependent Hydrogen Peroxide Formation Activity But Does Not Inhibit Superoxide-Dependent Hydrogen Peroxide Formation

View page
US Patent:
6638711, Oct 28, 2003
Filed:
Apr 28, 2000
Appl. No.:
09/560883
Inventors:
Ashley I. Bush - Somerville MA
Xudong Huang - Andover MA
Craig S. Atwood - Brecksville OH
Rudolph E. Tanzi - Hull MA
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
C12Q 100
US Classification:
435 4, 436 80, 436 84, 436127, 530350
Abstract:
The invention relates to methods for identifying candidate pharmacological agents to be used in the treatment and/or prevention of Alzheimers disease and/or related pathological conditions.

Composition Comprising A Metal Chelator And A Method Of Treating Amyloidosis By Administering The Metal Chelator

View page
US Patent:
7045531, May 16, 2006
Filed:
Mar 11, 1998
Appl. No.:
09/380704
Inventors:
Ashley I. Bush - Somerville MA, US
Xudong Huang - Cambridge MA, US
Craig S. Atwood - Cleveland OH, US
Rudolph E. Tanzi - Hull MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A61K 31/47
A61K 31/53
A61K 31/40
A61K 31/105
US Classification:
514311, 514244, 514420, 514707
Abstract:
The invention relates to the identification of pharmacological agents to be used in the treatment of Alzheimer's disease and related pathological conditions. Methods and compositions for treatment of conditions caused by amyloidosis, Aβ-mediated ROS formation, or both, such as Alzheimer's disease, are disclosed.

Methods For Identifying Agents That Inhibit Cell Migration, Promote Cell Adhesion And Prevent Metastasis

View page
US Patent:
8110355, Feb 7, 2012
Filed:
Feb 22, 2010
Appl. No.:
12/709897
Inventors:
Craig S. Atwood - Madison WI, US
Sivan Vadakkadath Meethal - Madison WI, US
Assignee:
GenRemedy, LLC - Cleveland OH
International Classification:
C12Q 1/68
C12P 19/34
C12N 5/00
C12N 5/02
C07H 21/04
US Classification:
435 61, 435 911, 435325, 435375, 536 245
Abstract:
Disclosed are methods for identification of agents that modulate cell attachment, cell migration and cell viability. Cancer and primary cells adhered to a matrix are treated with agent(s) that modulate ActRII signaling and cell adhesion. Agents are tested that modulate cell adhesion, detachment, invasion and viability. Agents that modulate the expression, phosphorylation, function and translocation of ActRII signaling pathway members also can predict agents that modulate cell adhesion, detachment, invasion and viability. The methods have utility in identifying agents that prevent cancer cell metastasis, wound dehiscence, aortic dissection and aid retina attachment and skin replacement and fertility.

Methods For Identifying Agents That Inhibit Cell Migration, Promote Cell Adhesion And Prevent Metastasis

View page
US Patent:
8329891, Dec 11, 2012
Filed:
Feb 6, 2012
Appl. No.:
13/366692
Inventors:
Craig S. Atwood - Madison WI, US
Sivan Vadakkadath Meethal - Madison WI, US
Assignee:
Genremedy LLC - Cleveland OH
International Classification:
C07H 21/02
C07H 21/04
C12Q 1/68
US Classification:
536 245, 435 61, 435 911
Abstract:
Disclosed are methods for identification of agents that modulate cell attachment, cell migration and cell viability. Cancer and primary cells adhered to a matrix are treated with agent(s) that modulate ActRII signaling and cell adhesion. Agents are tested that modulate cell adhesion, detachment, invasion and viability. Agents that modulate the expression, phosphorylation, function and translocation of ActRII signaling pathway members also can predict agents that modulate cell adhesion, detachment, invasion and viability. The methods have utility in identifying agents that prevent cancer cell metastasis, wound dehiscence, aortic dissection and aid retina attachment and skin replacement and fertility.

Method Of Screening For Drugs Useful In Treating Alzheimer's Disease

View page
US Patent:
20050112543, May 26, 2005
Filed:
Aug 19, 2003
Appl. No.:
10/643226
Inventors:
Ashley Bush - Somerville MA, US
Xudong Huang - Andover MA, US
Craig Atwood - Brecksville OH, US
Rudolph Tanzi - Hull MA, US
International Classification:
C12Q001/00
A61K031/519
US Classification:
435004000, 514220000, 514259410
Abstract:
The invention relates to methods for identifying candidate pharmacological agents to be used in the treatment and/or prevention of Alzheimer's disease and/or related pathological conditions.

Methods For The Modulation Of Brain Progestagen Signaling In The Prevention And Treatment Of Neurological Disorders And Neurodegenerative Diseases

View page
US Patent:
20100028360, Feb 4, 2010
Filed:
Jul 24, 2009
Appl. No.:
12/508676
Inventors:
Craig Stephen Atwood - Madison WI, US
International Classification:
A61K 39/395
A61K 31/56
A61K 38/16
A61K 38/08
A61K 31/7052
C12N 5/00
C12N 5/0735
A61P 25/00
US Classification:
4241581, 514177, 514170, 514 12, 514 15, 514 44 A, 435377, 435366
Abstract:
The present invention relates to methods for modulating progestagen signaling for treating neurological disorders or neurodegenerative disease, or preventing or delaying its onset in individuals deemed by competent observation and testing to be susceptible thereto. Progestagens can be administered to elevate serum and brain levels of progestagens and induce neurogenesis. Progestagen therapy may prevent some of the neurodegenerative and cognitive changes associated with developmental and aging associated neurological disorders and neurodegenerative diseases. Progestagen therapy together with suppression of GnRH, kisspeptin, LH and/or FSH signaling also may be used for treating neurological disorders or neurodegenerative diseases. The invention also relates to methods for inhibiting or delaying blastulation during embryogenesis, and neurogenesis during embryogenesis, fetal, neonatal, childhood, puberty or adult life. Blocking progestagen, estrogen and/or opioid signaling with receptor antagonists will inhibit neurogenesis. The invention also relates to using progestagens in vitro to induce neurogenesis in embryonic or adult stem cells.

Methods For Assessing Risk Of Alzheimer's Disease In A Patient

View page
US Patent:
20100035266, Feb 11, 2010
Filed:
Jul 28, 2009
Appl. No.:
12/510607
Inventors:
Craig S. Atwood - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
Disclosed are methods for diagnosis or prognosis of Alzheimer's disease in a patient. The methods may include assessing whether a patient has Alzheimer's disease or assessing a patient's risk for developing Alzheimer's disease. The methods typically include determining, either directly or indirectly, whether the patient has mutations, such as single nucleotide polymorphisms, in a plurality of genes that encode gene products that function in steroid biosynthesis.

Methods For Assessing Risk Of Alzheimer's Disease In A Patient

View page
US Patent:
20120003649, Jan 5, 2012
Filed:
Aug 8, 2011
Appl. No.:
13/205289
Inventors:
Craig S. Atwood - Madison WI, US
Assignee:
WISCONSIN ALUMNI RESEARCH FOUNDATION - Madison WI
International Classification:
C12Q 1/68
US Classification:
435 611
Abstract:
Disclosed are methods for diagnosis or prognosis of Alzheimer's disease in a patient. The methods may include assessing whether a patient has Alzheimer's disease or assessing a patient's risk for developing Alzheimer's disease. The methods typically include determining, either directly or indirectly, whether the patient has mutations, such as single nucleotide polymorphisms, in a plurality of genes that encode gene products that function in steroid biosynthesis.
Control profile
Craig S Atwood from Fitchburg, WI, age ~60 Get Report